Long‐term follow‐up after endovascular treatment of aortic coarctation with bare and covered Cheatham platinum stents

Abstract

AbstractBackgroundEndovascular treatment of aortic coarctation (CoA) in children and adults frequently requires stent implantation. The aim of this study was to analyze long‐term results after CoA treatment with bare and covered Cheatham‐PlatinumTM (CP) stents in our institution and to derive recommendations for the differential use of these stent types.MethodsIn this retrospective single institution study, 212 patients received endovascular CoA treatment with bare (n = 71) and covered (n = 141) CP stents between September 1999 and July 2021, respectively. The indications for treatment were native CoA in 110/212 patients (51.9%) and re‐coarctation after primary surgical or interventional treatment in 102/212 patients (48.1%). Median patient age at endovascular CoA treatment was 18.8 years [IQR 11.9; 35.8]. Long‐term follow‐up was available in 158/212 patients (74.5%) with a median follow‐up of 7.3 years [IQR 4.3; 12.6].ResultsProcedural success was achieved in 187/212 (88.2%) patients. Survival rate was 98.1% after 5, and 95.6% after 10 and 15 years, respectively. The probability of freedom from re‐intervention was 93.0% after 5, 82.3% after 10 and 77.8% after 15 years, respectively. Freedom from re‐interventions (44/158, 27.8%) did not differ between patients who received bare or covered CP stents (p = 0.715). Multivariable risk factor analysis identified previous CoA surgery (HR: 2.0, 95% confidence interval (CI): 1.1–3,9, p = 0.029), postdilatation (HR: 2,9, 95% CI: 1.1–6.3, p = 0.028) and age at intervention (HR: 0.96, 95% CI: 0.94–0.99, p = 0.002) as independent risk factors for re‐intervention. Peri‐procedural complications occurred in 15/212 (7.1%) patients (dissection/thrombosis of vascular access vessel: n = 9; bleeding: n = 1; stent dislocation: n = 2; aortic dissection/aortic wall rupture: n = 3). Long‐term complications were observed in 36 patients and included stent fracture (n = 19), aneurysm formation (n = 14), endoleak (n = 1) and subclavian artery stenosis (n = 2). Peri‐procedural and long‐term complications did not differ between patients who received CoA treatment with bare or covered CP stents (all p > 0.05).ConclusionEndovascular treatment of CoA using bare or covered CP stents can be performed safely and effectively with excellent long‐term results. Survival, re‐intervention and complication rate did not significantly differ between both stent types. However, individual stent selection is advisable with regard to CoA morphology and severity as well as patient age.